Mediterranean spotted fever (MSF) is a rickettsiosis caused by Rickettsia conorii. The antimicrobial therapy of rickettsiosis has not changed over the years. Tetracycline is still considered to be the drug of choice (1, 5) , with chloramphenicol as an alternative. The risk of developing aplastic anemia with chloramphenicol is well known (6) . In a case of intolerance to therapy with tetracycline, the physician must have an alternative treatment. We have previously reported the in vitro susceptibility of R. conorii to ciprofloxacin, a electrolytes, and liver function were carried out before, during, and after treatment. All of the patients were evaluated 15 and 30 days after the end of antibiotic therapy.
Five patients (four males and one female) with MSF were studied. Their ages ranged from 25 to 42 years (Table 1) . Four patients responded with defervescence and became afebrile within 3 days. Patient 5 was suffering from acquiredimmunodeficiency-syndrome-related complex (ARC) and was a heroin addict. He presented with a malignant form of (3) . He became afebrile in 7 days and completely recovered after a weight loss of 7 kg. All five patients were cured, and no side effects were noticed.
In this preliminary work, five patients with MSF were cured by treatment with ciprofloxacin. The time until apyrexia was essentially the same as that observed with tetracycline, i.e., 2 to 3 days (1, 5). One patient, who had a malignant form of the disease and ARC, had a slower but ultimately good response. The lethality is 50% in this form of the disease (3) . Predisposing factors to MSF include old age, alcoholism, diabetes, and glucose 6-phosphate dehydrogenase deficiency. This is the first reported case of MSF in an ARC patient. Ciprofloxacin at 6 mg/kg is considered sufficient for treating serious infections (2) . The MIC of ciprofloxacin for R. conorii is 0.5 ,ug/ml, as determined by the plaque assay (4) . The levels of the drug in serum were determined four times by high-pressure liquid chromatography. One hour after injection these concentrations ranged between 1.3 and 7.8 ,ug/ml, and 12 h after injection they ranged between 0.16 and 0.32 ,ug/ml. We 
